4basebio Plc

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BMCLYF79
GBP
7.12
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'11
Mar'11
Dec'10
Sep'10
Jun'10
Mar'10
Dec'09
Net Sales
124.16
118.76
117.70
120.82
107.73
101.07
100.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
124.16
118.76
117.70
120.82
107.73
101.07
100.03
Raw Material Cost
46.47
50.26
46.43
44.09
42.15
37.99
38.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
64.68
0.00
52.46
50.64
44.78
40.02
38.65
Other Expenses
1.69
0.00
1.54
1.51
1.20
1.22
1.21
Total Expenditure (Excl Depreciation)
128.02
50.26
114.29
109.81
98.98
90.22
88.96
Operating Profit (PBDIT) excl Other Income
-3.9000000000000004
68.5
3.4000000000000004
11
8.7
10.8
11.100000000000001
Other Income
-0.19
0.00
1.92
0.40
-0.33
-0.51
0.28
Operating Profit (PBDIT)
-3.86
15.19
3.41
11.01
8.75
10.85
11.08
Interest
2.94
3.16
3.23
3.18
2.91
2.89
3.12
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
77.69
68.50
71.27
76.73
65.57
63.08
61.85
Depreciation
13.82
15.25
15.55
14.95
14.27
13.61
14.11
Profit Before Tax
-6.98
-4.96
2.10
8.22
5.51
7.46
8.33
Tax
-2.92
-1.60
0.58
2.49
1.15
2.42
0.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-4.06
-3.36
1.51
5.73
4.36
5.04
7.71
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-4.06
-3.36
1.51
5.73
4.36
5.04
7.71
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-4.06
-3.36
1.51
5.73
4.36
5.04
7.71
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
422.56
412.55
408.08
389.21
377.28
359.67
331.47
Earnings per share (EPS)
-0.12
-0.1
0.04
0.16
0.13
0.15
0.23
Diluted Earnings per share
-0.12
-0.1
0.04
0.16
0.13
0.15
0.23
Operating Profit Margin (Excl OI)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
PAT Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2011 is 15.32% vs 16.94% in Jun 2010

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2011 is -193.18% vs 207.32% in Jun 2010

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2011 is -140.66% vs 46.77% in Jun 2010

stock-summary

Interest

YoY Growth in quarter ended Jun 2011 is 0.00% vs -3.33% in Jun 2010

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2011 has improved from Jun 2010

Compare Quarterly Results Of 4basebio Plc With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(GBP)
Change(%)
Net Sales
124.16
0
124.16
Other Operating Income
0.00
0.00
0.00
Total Operating income
124.16
0
124.16
Raw Material Cost
46.47
0
46.47
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0
0
0.00
Selling and Distribution Expenses
64.68
0
64.68
Other Expenses
1.69
0.00
1.69
Total Expenditure (Excl Depreciation)
128.02
0
128.02
Operating Profit (PBDIT) excl Other Income
-3.86
0.00
-3.86
Other Income
-0.19
0
-0.19
Operating Profit (PBDIT)
-3.86
0
-3.86
Interest
2.94
0
2.94
Exceptional Items
0
0
0.00
Gross Profit (PBDT)
77.69
0
77.69
Depreciation
13.82
0
13.82
Profit Before Tax
-6.98
0
-6.98
Tax
-2.92
0
-2.92
Provisions and contingencies
0
0
0.00
Profit After Tax
-4.06
0
-4.06
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-4.06
0
-4.06
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-4.06
0
-4.06
Equity Capital
0
0
0.00
Face Value
0.01
0
0.00
Reserves
422.56
0
422.56
Earnings per share (EPS)
-0.12
0
-0.12
Diluted Earnings per share
-0.12
0
-0.12
Operating Profit Margin (Excl OI)
0%
0%
0.00
0.00%
Gross Profit Margin
0%
0%
0.00
0.00%
PAT Margin
0%
0%
0.00
0.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 12.42 Million
in Jun 2011

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2011 is 4.55% vs 0.93% in Mar 2011

stock-summary

YoY Growth in quarter ended Jun 2011 is 15.32% vs 16.94% in Jun 2010

Quarterly - Consolidate Net Profit
Consolidate Net Profit -0.41 Million
in Jun 2011

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2011 is -20.59% vs -326.67% in Mar 2011

stock-summary

YoY Growth in quarter ended Jun 2011 is -193.18% vs 207.32% in Jun 2010

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.37 Million
in Jun 2011

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2011 is -124.34% vs 913.33% in Mar 2011

stock-summary

YoY Growth in quarter ended Jun 2011 is -140.66% vs 46.77% in Jun 2010

Quarterly - Interest
Interest 0.29 Million
in Jun 2011

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2011 is -9.38% vs 0.00% in Mar 2011

stock-summary

YoY Growth in quarter ended Jun 2011 is 0.00% vs -3.33% in Jun 2010

Quarterly - Operating Profit Margin (Excl OI)
Markets Mojo
No Operating Profit Margin (Excl OI) in the last few periods